Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilie P Buddingh

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 5, 2024
Use of proxy indicators for automated surveillance of severe acute respiratory infection, the Netherlands, 2017 to 2023: a proof-of-concept studyMaaike C Swets, Annabel Niessen, Emilie P Buddingh, et al.
Clinical Sarcoma Research|May 17, 2012
Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysisDagmar Berghuis, Marco W Schilham, Hanneke I Vos, et al.
Transplantation and Cellular Therapy|June 18, 2022
Clinical Features, Treatment, and Outcome of Pediatric Steroid Refractory Acute Graft-Versus-Host Disease: A Multicenter StudyAnne B Verbeek, Suze A Jansen, Erik G J von Asmuth, et al.
Cancer Immunology, Immunotherapy : CII|March 10, 2012
Intact interferon signaling in peripheral blood leukocytes of high-grade osteosarcoma patientsEmilie P Buddingh, S Eriaty N Ruslan, Dagmar Berghuis, et al.
The Journal of Pathology|September 1, 2009
Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2Alexander B Mohseny, Karoly Szuhai, Salvatore Romeo, et al.
BMC Medical Genomics|January 23, 2014
Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapyMarieke L Kuijjer, Brendy E W M van den Akker, Riet Hilhorst, et al.
Bone Marrow Transplantation|April 15, 2025
Pre-transplant inflammation and its associations with acute GvHD and mortality in pediatric allogeneic hematopoietic stem cell transplantation patientsAnne B Verbeek, Erik G J von Asmuth, Erik B van den Akker, et al.
Immunology Letters|June 3, 2026
No expansion of MIS-C associated TCR Vβ 21.3<sup>+</sup> T-cells in pediatric Post-COVID ConditionAdam J Tulling, Marloes G Holierhoek, Savannah N van der Kroft, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2011
Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agentsEmilie P Buddingh, Marieke L Kuijjer, Ronald A J Duim, et al.
Clinical Sarcoma Research|June 25, 2015
Mesenchymal stromal cells of osteosarcoma patients do not show evidence of neoplastic changes during long-term cultureEmilie P Buddingh, S Eriaty N Ruslan, Christianne M A Reijnders, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 5, 2024
Use of proxy indicators for automated surveillance of severe acute respiratory infection, the Netherlands, 2017 to 2023: a proof-of-concept studyMaaike C Swets, Annabel Niessen, Emilie P Buddingh, et al.
Clinical Sarcoma Research|May 17, 2012
Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysisDagmar Berghuis, Marco W Schilham, Hanneke I Vos, et al.
Transplantation and Cellular Therapy|June 18, 2022
Clinical Features, Treatment, and Outcome of Pediatric Steroid Refractory Acute Graft-Versus-Host Disease: A Multicenter StudyAnne B Verbeek, Suze A Jansen, Erik G J von Asmuth, et al.
Cancer Immunology, Immunotherapy : CII|March 10, 2012
Intact interferon signaling in peripheral blood leukocytes of high-grade osteosarcoma patientsEmilie P Buddingh, S Eriaty N Ruslan, Dagmar Berghuis, et al.
The Journal of Pathology|September 1, 2009
Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2Alexander B Mohseny, Karoly Szuhai, Salvatore Romeo, et al.
BMC Medical Genomics|January 23, 2014
Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapyMarieke L Kuijjer, Brendy E W M van den Akker, Riet Hilhorst, et al.
Bone Marrow Transplantation|April 15, 2025
Pre-transplant inflammation and its associations with acute GvHD and mortality in pediatric allogeneic hematopoietic stem cell transplantation patientsAnne B Verbeek, Erik G J von Asmuth, Erik B van den Akker, et al.
Immunology Letters|June 3, 2026
No expansion of MIS-C associated TCR Vβ 21.3<sup>+</sup> T-cells in pediatric Post-COVID ConditionAdam J Tulling, Marloes G Holierhoek, Savannah N van der Kroft, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2011
Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agentsEmilie P Buddingh, Marieke L Kuijjer, Ronald A J Duim, et al.
Clinical Sarcoma Research|June 25, 2015
Mesenchymal stromal cells of osteosarcoma patients do not show evidence of neoplastic changes during long-term cultureEmilie P Buddingh, S Eriaty N Ruslan, Christianne M A Reijnders, et al.
Pageof 4